- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Wild-type IDH1 inhibition enhances chemotherapy response in melanoma ; volume:41 ; number:1 ; day:24 ; month:9 ; year:2022 ; pages:1-18 ; date:12.2022
Journal of experimental & clinical cancer research ; 41, Heft 1 (24.9.2022), 1-18, 12.2022
- Urheber
-
Zarei, Mehrdad
Hajihassani, Omid
Hue, Jonathan J.
Graor, Hallie J.
Loftus, Alexander W.
Rathore, Moeez
Vaziri-Gohar, Ali
Asara, John M.
Winter, Jordan M.
Rothermel, Luke D.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-022-02489-w
- URN
-
urn:nbn:de:101:1-2022121221121561549717
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zarei, Mehrdad
- Hajihassani, Omid
- Hue, Jonathan J.
- Graor, Hallie J.
- Loftus, Alexander W.
- Rathore, Moeez
- Vaziri-Gohar, Ali
- Asara, John M.
- Winter, Jordan M.
- Rothermel, Luke D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Wild-type and mutated IDH1/2 enzymes and therapy responses
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas
Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone
Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone
MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species
Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy
Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients
Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas
Wild-type and mutated IDH1/2 enzymes and therapy responses
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas
Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone
Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone
MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species
Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy
Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients
Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas
Wild-type and mutated IDH1/2 enzymes and therapy responses
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas
Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone
Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone
MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species
Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy
Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients